Report No. 027 · Thu, 8 Oct 2026

Startup Scout: General Medicine

Pick of the day

General Medicine

A San Francisco startup building an online healthcare store where patients can shop for medications, labs, telehealth and specialist visits with upfront, insurance-aware pricing.

generalmedicine.co

Healthcare / Digital Health Marketplace · San Francisco

Series B · $120M

36/50Scout score

Problem: 7
Traction: 7
Founders: 8
Market: 8
Novelty: 6

Why today

Today's pick is General Medicine, the San Francisco healthcare marketplace that closed a 120 million dollar Series B announced October 6, 2026, led by Andreessen Horowitz with Eli Lilly and Mercy Health joining as strategic backers. Against a day of funding news that included a 38 million dollar seed close for a London stablecoin payments company, a 90 million dollar Series B for an open-source AI agent lab, a round for a Ukrainian drone maker, and a seed round for an AI agent tooling startup, General Medicine stands out because it is a healthcare company run by repeat founders who already built and sold one large consumer health business, now raising from a16z, a major pharmaceutical maker and a hospital system in the same round.

Problem

Shopping for healthcare in the United States means navigating a maze of separate providers, payers, labs and pharmacies, each with opaque pricing that frequently does not reflect what a patient's insurance will actually cover. Patients often cannot find a single place to compare costs across medications, lab work, specialist consults and in-person visits before they commit, and many digital health upstarts solve only one piece of that journey. The result is that people either overpay, delay care, or fall back on fragmented point solutions that do not talk to each other.

Product

General Medicine describes itself as a healthcare store: a marketplace spanning more than 2,900 products and services, including medications, lab tests, telehealth visits, specialist e-consults and select in-person visits and procedures. Patients can pay with cash or insurance, and the company shows upfront pricing calculated against an individual's own health plan rather than a generic cash rate, a model that differentiates it from cash-only direct-to-consumer telehealth rivals. The company says large language models have made it practical to read a person's coverage and benefits and map that to real service prices across facilities.

Traction

General Medicine launched nationwide in May 2025 and has since signed up hundreds of thousands of customers, reporting an average Net Promoter Score of 80. The company raised 32 million dollars in an earlier round roughly a year before this Series B, when it was already serving patients ahead of its broad public launch. The new 120 million dollar round brings its total disclosed funding to 152 million dollars, and the company plans to use the capital to expand into more care categories and standardize infrastructure across patients, clinicians, payers, labs and health systems.

Team

General Medicine was founded in 2023 by TJ Parker and Elliot Cohen, who previously co-founded the online pharmacy PillPack and sold it to Amazon for roughly 750 million dollars in 2018. They were joined by Ashwin Muralidharan, who had advised Amazon's top health executive before joining as a co-founder. With this round, Parker is taking the chief executive role full time, while Cohen serves as executive chair; sources differ on Muralidharan's exact current title.

Funding

The 120 million dollar Series B was announced October 6, 2026, led by Andreessen Horowitz, with general partner Vineeta Agarwala leading the investment for the firm. Matrix, VXI Capital, BoxGroup, Eli Lilly and Company, and Mercy Health, investing through Granger Management, also participated. The round follows a 32 million dollar round roughly a year earlier led by Matrix, bringing General Medicine's total disclosed funding to 152 million dollars less than three years after founding.

Competitors

General Medicine competes with a growing field of direct-to-consumer telehealth and online pharmacy startups, many of which operate on a cash-only basis with flat, non-insurance pricing. By accepting insurance and calculating upfront costs against a patient's own plan, the company is betting that insurance-aware pricing is a stronger wedge than the cash-pay model most digital health challengers have relied on. Its advantage rests on Parker and Cohen's experience building and scaling PillPack inside a highly regulated, trust-sensitive category, though incumbents with deeper payer relationships could still move to copy the pricing approach.

VC lens

Would YC fund it? Yes: repeat founders who already built and exited a large consumer health company, hundreds of thousands of customers and an 80 NPS within 18 months of launch, and a cap table that now includes a major pharma maker and a hospital system are a rare combination for a healthcare marketplace.

Biggest risk: General Medicine is still proving that insurance-aware upfront pricing can scale across the thousands of regional payer and provider combinations in US healthcare without the margin erosion that has sunk other healthcare marketplaces. If growth into new care categories slows or payer partnerships prove harder to standardize than expected, the jump from a 32 million dollar round to a 120 million dollar Series B in about a year will be hard to justify.

Runners-up

Noah

38 million dollar seed round, combining an original 22 million dollar raise with a fresh 16 million dollar top-up, for the London fintech building stablecoin infrastructure for enterprise cross-border payments. (Oct 7)

Nous Research

90 million dollar Series B led by Robot Ventures at a 1.5 billion dollar valuation for the open-source AI agent lab behind Hermes, with Nvidia and Union Square Ventures also participating. (Oct 7)

Buntar Aerospace

16 million dollar funding round led by Freedom Fund for the Ukrainian defense-tech company building GPS-free reconnaissance drones and mission-planning software for frontline units. (Oct 5)

Monid

7.7 million dollar seed round led by Long Journey Ventures for the San Francisco startup building a unified checkout and tool catalog that lets AI agents find, test and pay for third-party APIs. (Oct 6)

Archive

38 reports · click a row to open it

Date	Winner	One-liner	Runners-up
2026-10-19	Modal Labs	750 million dollar Series D led by Accel at a 15.75 billion dollar valuation, as the AI infrastructure startup says its annualized run rate crossed 1 billion dollars with usage tripling in five months, built on serverless GPU access for inference, training and agent sandboxes	OMass Therapeutics, Scanntech, North.cloud, Fortem Technologies
2026-10-18	Mueon	65 million dollar Series A led by Maverick Silicon, as the Portland semiconductor startup founded by two Intel veterans scales Cubelets, modular 3D blocks bundling compute, memory, power and cooling to cut AI data center power and density limits, already in use by AI chip startup d-Matrix	Estuary Biotherapeutics, Fission, Otter Health, HyLight
2026-10-17	Chariot Claims	10 million dollar Series A led by Silverton Partners, as the rebranded ClaimClam legal-tech platform scales automated matching of consumers to mass arbitration and class-action claims over hidden fees and hard-to-cancel subscriptions, building on more than 65,000 claims already processed toward an estimated 92 million dollars in settlements	Marklo, Siena, Rein Security, Peppermint
2026-10-16	Salience Labs	125 million dollar oversubscribed Series B led by Bullhound Capital, as the Oxford-spun-out photonics company wins new backing from AMD Ventures and Intel Capital for all-optical circuit switches meant to break the power and latency ceiling facing electronic switches as AI GPU clusters scale toward tens of thousands of chips	Navra, Type One Energy, Oratomic, Gallatin AI
2026-10-15	Soufflé Therapeutics	135 million dollar Series B led by Juvia Group, as the MIT bioengineer Robert Langer-founded biotech works to deliver RNA medicines to muscle and heart tissue, a problem that has stalled the entire siRNA drug class, backed by more than 3.5 billion dollars in big pharma partnerships before any program has reached the clinic	ICON, Pluto Security, Nous Research, Atomic Machines
2026-10-14	Vitalize	31 million dollar Series A led by Oak HC and FT, as the Y Combinator-backed startup unifying hospital staffing, scheduling, patient flow and capacity management expands after enterprise customers reported cutting manual scheduling work and premium labor spend	Gallatin AI, byteXL, Desible.ai, Credfix
2026-10-13	Universal Quantum	100 million dollar Series A co-led by DCVC and Firgun Ventures, a record raise for a UK quantum computing company, as the University of Sussex spinout races to prove its modular trapped-ion chiplet interconnect can out-scale newly public rivals Quantinuum and IonQ	Atlas Atomics, Type One Energy, Sabi, Catalyst
2026-10-12	Manus	500 million dollar funding round led by Boyu Capital and IDG Capital, the general AI agent's first raise since China blocked Meta's 2 billion dollar bid for the company and barred its founders from leaving the country, as Manus pursues a reported 4 billion dollar valuation on roughly 125 million dollars of annualized revenue	Oratomic, Matchpoint Therapeutics, Oxide Computer, Stuut
2026-10-11	Arena	200 million dollar Series B co-led by Lightspeed Venture Partners and Khosla Ventures at a 3.1 billion dollar valuation, as the company behind the Chatbot Arena leaderboard nearly doubles its valuation in ten months on roughly 100 million dollars of annualized revenue from selling AI evaluation and alignment benchmarking to labs and enterprises, while Scale AI's new Seal Showdown contests its neutral-referee position	Gallatin AI, Rein Security, Rivercell, TeddyHoldings.AI
2026-10-10	Multiply Labs	75 million dollar Series B led by Patrick Soon-Shiong's NantWorks with new investors AstraZeneca, Lingotto, Teradyne and Strange Ventures, as the decade-old biologics-manufacturing robotics company passes 100 million dollars raised on the strength of its first commercial sale, an up to 85 million dollar deal with Retro Biosciences, while competing against well-funded rivals Cellares and Ori Biotech to automate cell and gene therapy production	Zomint, Parakeet Health, OuterSignal, Efficient Computer
2026-10-09	RougeTx	58 million dollar Series A led by BioGeneration Ventures and Angelini Ventures with the European Investment Bank's Aurea facility and Kurma Partners also investing, as the Leiden University Medical Center spinout launches the first disease-modifying candidate for hereditary hemorrhagic telangiectasia, a bleeding disorder with no approved therapies, built on more than two decades of pericyte research	GMI Cloud, Varda Space Industries, doxx.net, Beyond Appliances
2026-10-08	General Medicine	120 million dollar Series B led by Andreessen Horowitz with Eli Lilly and Mercy Health joining, as the PillPack founders' online healthcare marketplace brings total funding to 152 million dollars less than three years after launch on hundreds of thousands of customers and an 80 Net Promoter Score	Noah, Nous Research, Buntar Aerospace, Monid
2026-10-07	Vinci	250 million dollar Series B at a 1.5 billion dollar valuation co-led by Advent, Temasek and Xora Innovation, as the Palo Alto physics foundation model startup jumps from a 46 million dollar seed and Series A disclosed last December to a tenfold valuation leap less than a year later, aiming its technology at chip design incumbents Cadence and Synopsys	Spiko, Hadrian, WhiteLab Genomics, Inbolt
2026-10-06	Pandektes	13.5 million euro Series A led by Munich's Alstin Capital, as the Copenhagen legal-research startup grows revenue sixfold and wins customers switching off LexisNexis, Westlaw, Beck and Karnov with an API-first legal data platform	OneByZero, Fleuret AI, Laki Power, RobCo
2026-10-05	PaleBlueDot AI	200 million dollar Series C at a 3.2 billion dollar valuation led by ComputeCore, as the Palo Alto AI compute platform nearly triples its valuation in under nine months on more than 5 billion dollars of signed customer contracts	Simple Energy, Elio Mortgage, Menos AI, SedMed
2026-10-04	Flow Engineering	50 million dollar Series B at a 750 million dollar valuation co-led by Valor Equity Partners and Atreides Management, as the AI-native systems-engineering platform for hardware teams grows to over 100 million requirements managed and adds General Motors, Anduril and Intuitive Machines as customers less than a year after its Series A	Miter, Kanu AI, Beltic, Satlyt
2026-10-03	EliseAI	350 million dollar round at a 4 billion dollar valuation led by Andreessen Horowitz and Bessemer Venture Partners, as the housing and healthcare conversational AI company nearly doubles its valuation in thirteen months on 200 million dollars of ARR and five straight years of 100 percent revenue growth	Kahua, Breye Therapeutics, Amara, Kuro
2026-10-02	Armadin	255.5 million dollar Series B co-led by Andreessen Horowitz and Accel at a 2.5 billion dollar valuation, as Mandiant founder Kevin Mandia's agentic attacker-swarm security platform runs live attack campaigns for Fortune 500 and government customers seven months after stealth	Foundational, Seeds Fincap, Numeral, Chamelio
2026-10-01	General Intuition	220 million dollar Series B at a 6.2 billion dollar valuation, nearly tripling in three months, as the AI foundation model startup trains action models on billions of gameplay clips from its own sister company Medal	Varda, Jeeves, Sand.ai, Arivihan
2026-09-30	Tiny Health	Oversubscribed $33M Series B led by B Capital as the at-home microbiome testing company posts 1,624% three-year revenue growth and quadruples its practitioner-facing business	Modulate, erad, Baselayer, Ande
2026-09-29	Instinct	$1B Series C led by Sequoia, Benchmark and Coatue at a $10B valuation, a roughly 4x jump in five weeks, as its text-message AI agent passes 100,000 users with 10% daily compounding growth	SiMa.ai, Quartermaster, Outmarket AI, Humanos
2026-09-28	Solcoa Industries	$75M seed ($45M equity led by Bain Capital Ventures plus $30M JPMorgan-anchored debt) to build a 500-tonne Nevada plant using a novel rare-earth metalmaking process, aimed at breaking China's 95% grip on metallization	Clastix, Prevision Medicine, Spiich, Barq
2026-09-27	Ultraviolette	$85M Series E led by Yali Capital and TDK Ventures; Bengaluru performance EV motorcycle maker plans US entry by 2027 on 4-5x revenue growth	Micro1, Kasvu Therapeutics, HIFI, Dextr AI
2026-09-26	Island	$400M Series F led by Evolution Equity Partners at a $6.4B valuation, more than doubling its 2024 valuation as the enterprise browser expands into governing AI agents	Cyera, Confido, Heidi Health, Firecrawl
2026-09-25	Ema	$77M Series B led by Creaegis, more than quadrupling its valuation as every existing backer doubled down and Wipro scales its AI Employees to 240,000+ workers	Ando, Kasvu Therapeutics, HIFI, Nuvah
2026-09-24	TEKEVER	$580M Series D led by UC Investments and Baillie Gifford; Ukraine-proven AI surveillance drone maker hits $6.4B valuation on a new 400M pound UK Army contract	Enveda Biosciences, Basecamp Research, Numeral, Brahma AI
2026-09-23	Verda	$189M oversubscribed Series B led by Emergence Capital; profitable Nordic GPU cloud crosses $1B valuation on $165M ARR	Snorkel AI, Nexstrom, MacroCycle, Demoverse
2026-09-22	BCI-Sonics	RMB 200M (~$30M) Pre-Series A led by HSG and Yunqi Capital; non-invasive ultrasound brain-computer interface racing China's invasive BCI leaders and OpenAI-backed Merge Labs	Spott, HighLife, CellPoint, Benford
2026-09-22	Amber Electric	€49M Series E led by Morgan Stanley's 1GT; automates 50%+ of Australia's home batteries, expanding VPP software into Europe via E.ON	Corridor, Paymob, Unit1 Studio, Drivn
2026-09-18	TypeSafe AI	$40M seed led by DCVC; "System One" model returns typed decisions for software, not chat — built by RLHF co-inventor Diogo Almeida	Space Epoch, Facilo, Treble Technologies, DheyaTech
2026-09-17	Exein	$270M Series C at $1.7B valuation (30x in 2 yrs); kernel-level security layer for robots, drones and autonomous machines	Anew Labs, Delos Data, CADDi, AIUC
2026-09-16	Euclyd	€200M+ Series A; Samsung-backed (investor + manufacturer) AI inference chip built to out-efficiency Nvidia, chaired by ex-ASML CEO	Profound, Flam, ENCOS, Nutshell Therapeutics
2026-09-15	Fortaegis	$50M oversubscribed Series A; quantum-safe security rooted in silicon, chaired by Quantinuum founder Ilyas Khan	Qupital, Tandem Health, Atomarine, UniqYou
2026-09-11	Positron AI	$875M Series C at $5B valuation; memory-first inference chips challenging Nvidia's HBM lock-in	The Boring Company, Mach Industries, Rogo Technologies, Swish
2026-09-10	Cognition AI	$2B+ Series E at $48B valuation; Devin autonomous coding agent nears $900M run-rate	DigitalPaani, Algomatic Dynamics, Limetax, Fundly.ai
2026-09-09	Bluecore Energy	Floating nuclear reactor barges for ports; $50M seed just 2 months after stealth launch	QNu Labs, ARC Ride, Circolife, Hope Care
2026-09-08	Pixxel	$100M Series C, India's largest spacetech round; building orbital AI data centers	Nua, Navana.ai, GalaxEye, Atoms (Kalanick)
2026-09-07	Medulance	GPS-dispatched ambulance network raises ₹24 Cr Series A-2	Comet, Mokobara, Kit (Speakeasy), XDOF

Sources

Compiled from search results: article pages were unreachable from the publishing environment on this date, so every fact here was cross-checked against at least two independent reports.